Authors


Ira Glick, MD

Latest:

A New Tool for Teaching Psychopharmacology

Everyone would probably agree that the practice of clinical psychiatry has changed profoundly over the second half of the past century. One of the most remarkable changes has been the rapid development and expansion of clinical psychopharmacology, which has become, like it or not, a dominant part of the clinical practice of most psychiatrists. Available treatments for mental disorders changed and our armamentarium broadened. We have numerous medications for psychiatric disorders. We even use medications for disorders traditionally considered only amenable to and suitable for psychotherapy.


Ira Steinman, MD

Latest:

Podcast: Pandora's Box and Integrative Treatment of Schizophrenia

Here, Dr Ira Steinman, discusses the concept behind "Beyond Pandora's Box: Exploring Integrative Approaches to Treating Psychosis."


Irene Abramovich, MD, PhD

Latest:

Do We Need Psychiatrists?

For a couple of years, I have been a member of the American Society of Clinical Psychopharmacology (ASCP). I guess many of us carry this need to belong from our adolescent years. It always felt good for me to be a part of a professional group, sharing the same interests, united by special education and knowledge. How wrong of me!


Irene Baldi, MD

Latest:

The Relationship Between Anxiety Disorders and Sexual Dysfunction

In this article, we examine the relationship between anxiety disorders and SDs, using DSM-IV-TR categories, although we are conscious of the limits of this approach. In doing so, we will consider not only the dichotomy between normal and pathological functioning but also the issue of sexual satisfaction as part of wellness.


Irene C. Coletsos, MD

Latest:

Can Epigenetics Promote Resilience Without Genetic Reductionism?

The emergence of epigenetic models has generated a surge of optimism, opening new possibilities for psychiatric intervention.


Irene M. Hurford, MD

Latest:

Treating Prodromal Symptoms of Psychosis

A review of some of the latest study findings on the pharmacological treatment of prodromal psychosis.


Irene Markman Geisner, MS

Latest:

Alternative Brief Interventions for Mild Depression

Depression has long been recognized as a primary concern for health care providers. Many approaches to treating depression have been developed, ranging from medications, to long-term psychotherapy, to shorter, more structured cognitive-behavioral treatments--all of which help some of the patients, some of the time, to some extent.


Irene Ortiz, MD

Latest:

New Directions in Psychiatry

In order to make positive changes in the field of psychiatry, it is important to appreciate and understand the current challenges and significant limitations of the present approach to psychiatric therapy.


Irina Kopeykina

Latest:

Violence in Bipolar Disorder

What is the association between bipolar disorder, trauma, and violence? Here: a guide to assessing violence potential in bipolar patients.


Iris M. Balodis, PhD

Latest:

Neurobiological Underpinnings of Obesity and Addiction: A Focus on Binge Eating Disorder and Implications for Treatment

This CME is intended to help differentiate binge eating disorder (BED) from other eating disorders and understand the mechanisms that may put BED into the realm of addiction disorders.


Iris R. Bell, MD, PhD

Latest:

Multiple Chemical Sensitivities

The patient who presents with vague psychiatric somatic complaints may, in fact, be suffering from chemical sensitivities. Such sensitivities are tied to lower incidences of certain psychiatric disorders while correlating with the higher prevalence of others. Neurogenic inflammation, limbic kindling and psychiatric co-factors are discussed.


Irving Kirsch, PhD

Latest:

STAR*D’s Cumulative Remission Rate and Why It Still Matters

Contesters of STAR*D discuss the impact and relevance of the study's remission rates.


Irwin Feinberg, MD

Latest:

A Unifying Premorbid Diagnosis

One cannot but be impressed at the ingenuity of our DSM-5 mavens at conjuring up new diagnostic syndromes.


Irwin H. Rosenberg, MD

Latest:

The Role of B Vitamins, Homocysteine in AD and Vascular Dementia

Alzheimer's disease (AD) is a devastating and debilitating neurodegenerative condition, and the most common cause of dementia among the elderly. Despite considerable advances in the cellular and molecular biology of AD, however, little progress has been made in identifying the causes of the disease.


Irwin Sander, PhD

Latest:

Preventive Interventions for Children of Divorce

Studies have shown that children of divorced parents may suffer more mental health problems, particularly conduct disorders. What programs might be effective in helping these children deal with the stress of their parents' divorce? Are there effective programs to teach parents better coping skills?


Isabelle Amado, MD, PhD

Latest:

Je Suis Charlie: A First-Person Account From the Paris Rally

A commentary on France's response to recent acts of terrorism that unified a nation and the world, co-written by a psychiatrist who was at the Paris Rally.


Ismene L. Petrakis, MD

Latest:

Addictive Disorders: Updates and Findings

An introduction to the Annual Meeting of the American Academy of Addiction Psychiatry and its coverage of topics such as alcohol use disorders, e-cigarettes, prescription opioid use and abuse, cannabis use, stimulant use, medical marijuana, gambling, and opioid antagonist therapy to prevent overdose.


Ismene Petrakis, MD

Latest:

Alcohol Disorders: Practical Tips From New Research

In this review, we discuss the established medications as well as experimental therapeutic options that may emerge as future medications for alcohol intoxication, withdrawal, and/or long-term abstinence maintenance or harm-reduced drinking.


Israel Kalman, MS

Latest:

A Fun, Powerful Technique for Teaching Children How to Stop Being Bullied

The bullying prevention program is very popular but not very effective because bullying is an inevitable part of life.


Ivn D. Montoya, MD, MPH

Latest:

Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders

What is comorbidity? Psychiatric comorbidity refers to the occurrence of 2 or more mental or substance use disorders within a certain period. Research shows that comorbidity of substance use and other psychiatric disorders is common and often worsens the prognosis for each disorder.


J. Alexander Bodkin, MD

Latest:

Adjunctive Treatment Options for Patients With Residual Symptoms of Depression

Patients with residual symptoms of depression may continue to experience significant occupational and social impairment. The focus of this article is on the residual burden that so often remains after remission is achieved.


J. Anderson Thomson Jr, MD

Latest:

Coyne Battles Darwin, Many Other Evolutionary Biologists-and Himself

Erroneous conclusions, and medical harm, can come from accepting any hypothesis uncritically, and growing evidence indicates that treatments based on disorder hypotheses for depression do cause harm.


J. Christopher Muran, PhD

Latest:

Mindfulness and the Medication Management Visit

Engaging in mindfulness activities either individually or with patients who come to us for brief medication visits can have a profound influence on the therapeutic process.


J. David Kinzie, MD

Latest:

7 Tips for Treating Trauma in Refugee Patients

Many refugees have been victims of severe violence that has profoundly affected their physical, psychological, and spiritual lives. Take home points here.


J. Douglas Bremner, MD

Latest:

PTSD in the Emergency Setting

The following 3 cases illustrate the diagnostic challenges related to differentiating brain injury and posttraumatic stress disorder (PTSD) in patients presenting to the emergency department (ED) in the acute period following a traumatic injury. Such patients pose a dilemma for ED clinicians because of the interplay between head injury and PTSD in the clinical presentation of cognitive impairments in the aftermath of trauma.


J. Edwin Nieves, MD

Latest:

A Literature Review of Videophone Use in Mental Health

In our survey, we found videophones a surprisingly understudied and underutilized tool in spite of the fact that they are easy to use and do not require any technical support.


J. John Mann, MD

Latest:

The Relationship Between Antidepressant Initiation and Suicide Risk

Ten years ago, the FDA placed a black box warning on all antidepressants because of concerns that the medications increase risk of suicidal thoughts and behavior in youths. It's time for the FDA reevaluate that decision.


J. M. Wright, MD, PhD

Latest:

New Directions in Psychiatry

In order to make positive changes in the field of psychiatry, it is important to appreciate and understand the current challenges and significant limitations of the present approach to psychiatric therapy.


J. Michael Ray, MD

Latest:

Knee pain in an 81-year-old man

An 81-year-old man presented to an urgent care facility with a 1-year history of pain in his right knee.


J. Paul Fedoroff, MD

Latest:

Mini Quiz: Treatment for Pedophilia?

What does the scientific evidence tell us about treatment for pedophilia? The answer might surprise you.

© 2024 MJH Life Sciences

All rights reserved.